Drug Trial Radar · NCT03614494
Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception
Last checked: Nov 19, 2026Latest source record: May 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
860
Actual
Start
Aug 20, 2018
Primary completion
Oct 5, 2022
Study completion Oct 5, 2022
Sponsor
- Lead sponsor
- Dr. Hang Wun Raymond LiAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- The Family Planning Association of Hong Kong
- First posted
- Aug 3, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a randomised controlled trial aimed at comparing the efficacy of levonorgestrel (LNG) co-administered with piroxicam or placebo for oral emergency contraception (EC). Piroxicam is a non-steroidal anti-inflammatory drug (NSAID) commonly used as a pain-killer in inflammatory conditions. Efficacy will be measured as the percentage of pregnancies prevented.
Conditions
- Emergency Contraception
Interventions
Piroxicam 40 mgDrug
Additional co-treatment
Levonorgestrel 1.5mgDrug
Standard treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Pregnancies PreventedTime frame: 1 month
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Queen Mary Hospital
Hong Kong, Hong Kong
The Family Planning Association of Hong Kong
Hong Kong, Hong Kong
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.